AstraZeneca’s Dapagliflozin tablets get DCGI nod for patients with chronic kidney disease – ET HealthWorld

AstraZeneca’s Dapagliflozin tablets get DCGI nod for patients with chronic kidney disease – ET HealthWorld

New Delhi: AstraZeneca Pharma India on Saturday said it has received approval from the Drugs…

View More AstraZeneca’s Dapagliflozin tablets get DCGI nod for patients with chronic kidney disease – ET HealthWorld